Mice Model
Mice Model Market by Type (Genetically Modified, Hybrid, Inbred), Application (Cancer Research, Drug Development, Genetic Research), End Users, Disease Model, Technology - Global Forecast 2025-2030
SKU
MRR-4316E4E89369
Region
Global
Publication Date
February 2025
Delivery
Immediate
2024
USD 1.61 billion
2025
USD 1.75 billion
2030
USD 2.61 billion
CAGR
8.39%
360iResearch Analyst Ketan Rohom
Download a Free PDF
Get a sneak peek into the valuable insights and in-depth analysis featured in our comprehensive mice model market report. Download now to stay ahead in the industry! Need more tailored information? Ketan is here to help you find exactly what you need.

The Mice Model Market size was estimated at USD 1.61 billion in 2024 and expected to reach USD 1.75 billion in 2025, at a CAGR 8.39% to reach USD 2.61 billion by 2030.

Mice Model Market
To learn more about this report, request a free PDF copy

Mice models are indispensable tools in biomedical research, offering a scope that spans numerous fields such as genetics, oncology, neurology, and pharmacology. These models are defined by their genetic similarity to humans, which allows researchers to simulate human disease conditions and predict human responses to treatments. The necessity of mice models is underscored by their role in advancing understanding of complex biological processes and accelerating drug development. Applications range from investigating disease mechanisms to testing new therapeutic interventions. The market's end-use scope predominantly includes academic and research institutions, pharmaceutical companies, and healthcare organizations. Key growth factors include the increasing prevalence of chronic diseases, demand for personalized medicine, and regulatory support for timely drug approvals. Emerging opportunities lie in the development of more refined genetic models and non-invasive imaging techniques, enhancing model accuracy and translatability to human conditions. However, the market faces limitations such as ethical concerns, high costs, and the complexity of accurately mimicking human diseases. The challenge of genetic and phenotypic variability also plays a role in market restraint. Addressing these challenges, innovations in CRISPR-Cas9 gene editing and advancements in artificial intelligence for data analysis are key areas for growth. The nature of the market is increasingly competitive, driven by technological advancements and strategic collaborations among industry players. Companies are encouraged to invest in the development of humanized mice models and explore joint ventures to diversify their research capabilities. Innovation in alternative methods such as in vitro systems and computer modeling is also vital to complement in vivo studies and address ethical issues. To capitalize on these opportunities, businesses should focus on integrating multidisciplinary approaches and leveraging technological advancements to enhance model precision and efficiency.

Ask ResearchAI anything

World's First Innovative Al for Market Research

Ask your question about the Mice Model market, and ResearchAI will deliver precise answers.
How ResearchAI Enhances the Value of Your Research
ResearchAI-as-a-Service
Gain reliable, real-time access to a responsible AI platform tailored to meet all your research requirements.
24/7/365 Accessibility
Receive quick answers anytime, anywhere, so you’re always informed.
Maximize Research Value
Gain credits to improve your findings, complemented by comprehensive post-sales support.
Multi Language Support
Use the platform in your preferred language for a more comfortable experience.
Stay Competitive
Use AI insights to boost decision-making and join the research revolution at no extra cost.
Time and Effort Savings
Simplify your research process by reducing the waiting time for analyst interactions in traditional methods.

Market Dynamics

The market dynamics represent an ever-changing landscape of the Mice Model Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Unveiling the expansion of academic and research institutions advocating for mice model adoption
    • Discovering how government funding and research grants are enhancing the potential of the mice model market
    • Identifying the rising trend of personalized medicine and its influence on the need for mice models
  • Market Restraints
    • Access to credible and comprehensive market data on laboratory mice models remains challenging
    • Regulatory stringencies and variations across regions complicate global market expansions
    • Laboratory infrastructure requirements can be prohibitively expensive for emerging market players
  • Market Opportunities
    • Advancing dietary supplements tailored specifically for improved health outcomes in research mice
    • Expanding educational workshops and resources to train researchers in ethical mice handling techniques
    • Opportunities for 3D bioprinting technologies in the creation of more realistic mice organ models
  • Market Challenges
    • Enhancing reproducibility and standardization of experimental outcomes in different mice models
    • Identifying and overcoming ethical concerns surrounding the use of mice models in research
    • Dealing with the increasing public scrutiny and advocacy against the use of animal models

Market Segmentation Analysis

  • Type: Growing significance of genetically engineered mice for evaluating gene therapy outcomes

    Conditioned or surgically modified mice are specifically altered through surgical interventions to create models that represent human conditions not naturally occurring in the mouse genome. These modifications can include the removal of specific organs, the introduction of tumors, or the creation of injury models. This methodology allows for the study of disease mechanisms, the development of surgical techniques, and the evaluation of therapeutics in a controlled environment, closely mimicking the human physiological conditions they aim to replicate. Genetically engineered mice (GEM) are created by manipulating their genetic material. Techniques such as gene knockout, gene knock-in, and transgenesis are employed to introduce, remove, or alter specific genes within the mouse genome. This category of mice models is important for studying gene function, the genetic basis of diseases, and the potential effects of genetic modifications. Hybrid/congenic mice are produced through controlled breeding strategies to combine genetic material from two or more strains to achieve specific genetic backgrounds. Hybrid mice result from mating two different inbred strains, offering heterozygosity and broader genetic diversity, which is beneficial for general health and reproductive performance. Congenic mice, on the other hand, are created by backcrossing hybrids to one of the original inbred strains for multiple generations, allowing for the isolation of specific genetic traits or loci. Inbred mice are derived from at least 20 generations of brother-sister or parent-offspring mating, which results in a genetically uniform strain. These mice are invaluable in research owing to their consistent genetic background, which minimizes variability in experimental studies. Inbred strains are used extensively in the study of genetics, immunology, and disease models, including as platforms for developing genetically engineered models and for pharmacological and toxicological studies. Outbred mice are genetically diverse populations that are kept deliberately heterozygous. This genetic variability mirrors the genetic diversity within human populations, making them particularly useful for toxicology, pharmacology, and safety assessment studies.

  • Application: Rising adoption of mice models to explore therapeutic efficacy and safety profiles before clinical trials

    The applications of mice models in drug discovery and development are essential for the pharmaceutical industry. The physiological and genetic similarities between humans and mice make them invaluable for assessing the efficacy and safety of new pharmaceutical compounds. By utilizing mice models, researchers can elucidate the pharmacokinetic and pharmacodynamic properties of potential therapeutic agents, enabling the identification of promising drug candidates for further development. Moreover, these models help in understanding the mechanism of action, dose-response relationship, and potential toxicity of new drugs before entering human clinical trials, thereby minimizing the risk of failure at later development stages. Mice models are pivotal in the advancement of personalized medicine. Using genetically engineered mice and patient-derived xenografts (PDX), researchers can mimic human genetic conditions and diseases at a high level of accuracy. This enables the study of individual responses to therapeutics based on genetic makeup, leading to more precise and effective treatment strategies. Personalized mice models are instrumental in identifying biomarkers for disease diagnosis, predicting therapeutic outcomes, and evaluating targeted therapies. Besides their significant role in drug development and personalized medicine, mice models are extensively used in various biomedical research applications. These include studying genetics, understanding disease mechanisms, testing immunological responses, and evaluating the impact of environmental factors on health. Mice models have been crucial in advancing our knowledge of complex diseases such as cancer, cardiovascular diseases, diabetes, and neurological disorders. Their versatility and adaptability also make them suitable for regenerative medicine studies and aging research, contributing profoundly to expanding biomedical knowledge and exploring new therapeutic avenues.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Mice Model Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

PESTLE Analysis

The PESTLE analysis offers a comprehensive tool for understanding and analyzing the external macro-environmental factors that impact businesses within the Mice Model Market. This framework examines Political, Economic, Social, Technological, Legal, and Environmental factors, providing companies with insights into how these elements influence their operations and strategic decisions. By using PESTLE analysis, businesses can identify potential opportunities and threats in the market, adapt to changes in the external environment, and make informed decisions that align with current and future conditions. This analysis helps companies anticipate shifts in regulation, consumer behavior, technology, and economic conditions, allowing them to better navigate risks and capitalize on emerging trends.

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Mice Model Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Mice Model Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Recent Developments

  • Biocytogen Officially Launches RenMice Series

    Biocytogen Pharmaceuticals (Beijing) Co., Ltd. introduced the RenMice series. This innovative collection features independently developed mice, including fully human antibody and TCR mice, RenMab, RenLite, RenNano, RenTCRâ„¢, and RenTCR-mimic, each holding proprietary intellectual property rights. The name "Ren," meaning "human" in Chinese, encapsulates the company's dedication to pushing the boundaries of novel therapeutic discovery and development for human health. [Published On: September 15, 2023]

  • Introducing NeoMab: GemPharmatech's Innovative Antibody Gene Humanized Mouse Model

    GemPharmatech has unveiled NeoMab, a full antibody gene humanized mouse model, culminating from four years of meticulous research and validation. Specifically tailored for the expanding needs of therapeutic antibody development in biotechnology and pharmaceutical sectors, NeoMab is engineered on the well-established BALB/c genetic foundation. This model masterfully combines the native mouse immune system's robustness with human-specific variable regions, thereby offering a potent tool for antibody discovery and research innovation. [Published On: August 21, 2023]

  • A Mouse That Roars: Chinese Scientists Create The First Mammal With Fully Reprogrammed Genes

    Chinese scientists have created its first fully functional mammal model. This new development marks a significant advancement in the field of biomedical research, which relies heavily on the use of mice as model organisms to simulate human physiology and diseases. The success of this experiment proves the feasibility of this cutting-edge technology, and also sets the stage for more sophisticated research in the years to come. [Published On: August 27, 2022]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Mice Model Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Mice Model Market, highlighting leading vendors and their innovative profiles. These include Applied StemCell, Inc., Aragen Life Sciences Ltd., Biocytogen Boston Corporation, Charles River Laboratories International, Inc., CompareNetworks, Inc., Creative Biolabs., Crown Bioscience by JSR Life Sciences, LLC, Cyagen US Inc. by PolyGene AG, Envigo by Inotiv, Inc., GenOway, Harbour BioMed, Horizon Discovery Ltd. by PerkinElmer, Inc., inGenious Targeting Laboratory, Inc., ITR Laboratories Canada, Janvier Labs, Marshall BioResources, MD Biosciences, Mirimus, Inc., Oncodesign, SA, Ozgene Pty Ltd., PhoenixBio Co., Ltd., Shanghai Model Organisms Center, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, TransCure bioServices, Translational Drug Development, LLC, Transnetyx, Inc., Urosphere SAS, Vivo Bio Tech Ltd., and XenOPAT SL by Bellvitge Biomedical Research Institute.

Market Segmentation & Coverage

This research report categorizes the Mice Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Genetically Modified
      • Knockout Mice
        • Conditional Gene Knockout
        • Total Gene Knockout
      • Transgenic Mice
        • Humanized Mice
        • Reporter Mice
    • Hybrid
      • Backcross Hybrids
      • F1 Hybrids
    • Inbred
      • Conditioned Inbred
      • Standard Inbred
    • Outbred
      • Randomly Bred
      • Swiss Mice
  • Application
    • Cancer Research
      • Metastasis Research
      • Tumorigenesis Studies
    • Drug Development
      • Preclinical Testing
      • Toxicology Studies
    • Genetic Research
      • Gene Function Analysis
      • Gene Regulation Studies
    • Neurobiology
      • Behavioral Studies
      • Neural Circuitry Analysis
  • End Users
    • Academic Institutions
      • University Research Centers
    • Biotechnology Companies
      • Development Departments
    • Contract Research Organizations (CROs)
      • Biomarker Discovery
      • Preclinical Services
    • Pharmaceutical Companies
      • Research Laboratories
  • Disease Model
    • Cardiovascular
      • Atherosclerosis
      • Heart Failure
    • Oncology
      • Breast Cancer
      • Lung Cancer
  • Technology
    • CRISPR/Cas9
      • Knock-In
      • Knock-Out
    • Gene Silencing Technologies
      • RNA Interference
    • TALEN
      • Gene Repair
    • Zinc Finger Nucleases
      • Gene Mutation Studies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Mice Model Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Mice Model Market, by Type
  7. Mice Model Market, by Application
  8. Mice Model Market, by End Users
  9. Mice Model Market, by Disease Model
  10. Mice Model Market, by Technology
  11. Americas Mice Model Market
  12. Asia-Pacific Mice Model Market
  13. Europe, Middle East & Africa Mice Model Market
  14. Competitive Landscape
  15. List of Figures [Total: 27]
  16. List of Tables [Total: 1114 ]
  17. List of Companies Mentioned [Total: 30]
Frequently Asked Questions
  1. How big is the Mice Model Market?
    Ans. The Global Mice Model Market size was estimated at USD 1.61 billion in 2024 and expected to reach USD 1.75 billion in 2025.
  2. What is the Mice Model Market growth?
    Ans. The Global Mice Model Market to grow USD 2.61 billion by 2030, at a CAGR of 8.39%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.